Literature DB >> 10651085

Systemic sclerosis and antineutrophil cytoplasmic autoantibody-associated renal failure.

A Katrib1, A Sturgess, J V Bertouch.   

Abstract

We report three patients who developed antineutrophil cytoplasmic autoantibody (ANCA)-associated crescentic glomerulonephritis, two of whom showed clinical features of limited scleroderma and one whose results of serological tests were suggestive of limited scleroderma without cutaneous features. All had anticentromere antibodies and antimyeloperoxidase antibodies. No patient showed the features of typical scleroderma renal crisis such as accelerated hypertension or microangiopathy. Our patients were normotensive at the time of onset of renal failure, and the clinical picture was characterised by only modest features of limited scleroderma. All three patients had crescentic glomerulonephritis at various stages of chronicity. One patient responded to immunosuppressive therapy with improvement in renal function; the other two patients rapidly developed end-stage renal failure. These patients and others recently described may represent a newly described form of scleroderma renal disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10651085     DOI: 10.1007/s002960050102

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  5 in total

Review 1.  Pauci-immune crescentic glomerulonephritis in limited cutaneous systemic sclerosis.

Authors:  P T Chan; C C Mok
Journal:  Clin Rheumatol       Date:  2012-05-30       Impact factor: 2.980

2.  Scleroderma associated with ANCA-associated vasculitis.

Authors:  Young Hee Rho; Seong Jae Choi; Young Ho Lee; Jong Dae Ji; Gwan Gyu Song
Journal:  Rheumatol Int       Date:  2005-07-13       Impact factor: 2.631

Review 3.  Scleroderma associated with ANCA-associated vasculitis.

Authors:  Young Hee Rho; Seong Jae Choi; Young Ho Lee; Jong Dae Ji; Gwan Gyu Song
Journal:  Rheumatol Int       Date:  2005-07-20       Impact factor: 2.631

4.  Fever of unknown origin secondary to type I crescentic glomerulonephritis and anti-SCl 70 antibodies without clinical manifestations of systemic sclerosis.

Authors:  Jorge Vega Stieb; Helmuth Goecke Saavedra; Gonzalo Méndez Olivieri
Journal:  Clin Exp Nephrol       Date:  2008-05-20       Impact factor: 2.801

Review 5.  The many faces of scleroderma sine scleroderma: a literature review focusing on cardiopulmonary complications.

Authors:  Sophie P Toya; George E Tzelepis
Journal:  Rheumatol Int       Date:  2009-02-27       Impact factor: 2.631

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.